SCHEMBL12477192

SCHEMBL12477192

CCCCON[C@@H](C)C(=O)OP(=O)(O)Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
ATM Q13315 1/20 0.33
RAB9A P51151 2/20 0.32
HPGD P15428 2/20 0.32
NPC1 O15118 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
MAPT P10636 2/20 0.32
LPAR3 Q9UBY5 3/20 0.32
LPAR1 Q92633 2/20 0.32
LPAR2 Q9HBW0 2/20 0.32
CYP3A4 P08684 1/20 0.32
S1PR2 O95136 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
TSHR P16473 1/20 0.31
ACHE P22303 1/20 0.31
MMP2 P08253 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28457433 0.94 LPAR3 (0.40) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL12477586 0.91
SCHEMBL7796592 0.85 MAPT (0.37) ALDH1A1ATMRAB9AHPGDNPC1
SCHEMBL21052575 0.84 MMP1 (0.31) MMP2
SCHEMBL17818353 0.84 MMP1 (0.31) MMP2
SCHEMBL12477657 0.78
SCHEMBL28455643 0.78
SCHEMBL3970115 0.77 TSHR (0.39) L3MBTL1TSHR
SCHEMBL3970116 0.77 TSHR (0.39) L3MBTL1TSHR
SCHEMBL4271904 0.76 S1PR2 (0.40) S1PR2S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2658857-B1 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS INHIBITEX INC (US) 2016-11-02 EP disclosed
EP-2658857-A2 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS Inhibitex, Inc. (US) 2013-11-06 EP disclosed
WO-2012092484-A2 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHOROAMIDATE AND PHOSPHORODIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS INHIBITEX, INC. (US) 2012-07-05 WO disclosed